InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
3
T+90 hit rate
38%
T+90 mean return
+8.7%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Hughes Douglas J., Director. Officer active across 2 companies, notably Immunovant, Inc.. Aggregated, 12 filings have been logged. Breakdown: 2 buys · 3 sells. Total volume traded: €925k. History available since 27 August 2021. The latest transaction was disclosed on 1 December 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
13,091 shares@ US$23.1433.6% of flowCommon StockSEC:0001764013-25-000159
13,091 shares@ US$23.140.0047% mcap33.6% of flowCommon StockSEC:0001764013-25-000159:0
16,188 shares0Common StockSEC:0001764013-25-000045:0
5,425 shares@ US$28.5415.9% of flowCommon StockSEC:0001764013-24-000199:0
11,255 shares0Common StockSEC:0001764013-24-000065:0
12,523 shares0Common StockSEC:0001764013-23-000046:0
71,363 shares@ US$0.50100.0% of flowCommon StockSEC:0000899243-22-037001:0
21,059 shares0Common StockSEC:0001764013-22-000091:0
21,726 shares0Common StockSEC:0001764013-22-000017
21,726 shares0Common StockSEC:0001764013-22-000017:0
18,247 shares@ US$8.240.0023% mcap16.4% of flowCommon StockSEC:0001764013-21-000092:0
Ideal exit: 24 May 2022 (T+270)
18,247 shares@ US$8.240.0023% mcap32.9% of flowCommon StockSEC:0001764013-21-000092
Ideal exit: 24 May 2022 (T+270)
12 of 12 declarations
About Hughes Douglas J.
Douglas J. Hughes is a Board Member at Immunovant, Inc. He brings a strategic perspective to the board, contributing to the direction and governance of the company. His diverse experience enriches discussions and decisions within the board.
